Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-29 @ 10:11 AM
Study NCT ID:
NCT05291234
Status:
COMPLETED
Last Update Posted:
2025-12-10
First Post:
2022-03-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-21
First Submit QC Date:
None
Study First Post Date:
2022-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-10
Last Update Post Date Type:
ESTIMATED